Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Gross Margin of 52.25% for Q1 2026, down 2.0% year-over-year from 53.32% in Q1 2025, and up 4.93% quarter-over-quarter from 49.8% in Q4 2025.
Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Gross Margin for 18 consecutive years, with 52.25% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 2.0% year-over-year to 52.25%; the TTM figure through Mar 2026 stood at 51.87% (down 161.0% YoY), while the FY2025 annual figure was 51.87%, down 186.0% from the prior year.
- Gross Margin advanced to 52.25% in Q1 2026 per BIO's latest filing, from 49.8% in the prior quarter.
- Across five years, Gross Margin topped out at 57.51% in Q1 2022 and bottomed at 49.8% in Q4 2025.
- Historically, Gross Margin has averaged 53.67% across 5 years, with a median of 53.36% in 2024.
- Annual changes were most pronounced in 2022 — Gross Margin soared 240 bps — and 2023, when it tumbled 396 bps.
- Bio-Rad Laboratories' Gross Margin stood at 54.37% in 2022, then dropped by 1 bps to 53.77% in 2023, then declined by 5 bps to 51.24% in 2024, then dropped by 3 bps to 49.8% in 2025, then increased by 5 bps to 52.25% in 2026.
- Business Quant data shows BIO's Gross Margin at 52.25% in Q1 2026, 49.8% in Q4 2025, and 52.59% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 45.84% |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 53.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.12% |
| Mar 31, 2026 | 52.25% |
| Dec 31, 2025 | 49.80% |
| Sep 30, 2025 | 52.59% |
| Jun 30, 2025 | 52.99% |
| Mar 31, 2025 | 52.27% |
| Dec 31, 2024 | 51.24% |
| Sep 30, 2024 | 54.78% |
| Jun 30, 2024 | 55.61% |
| Mar 31, 2024 | 53.36% |
| Dec 31, 2023 | 53.77% |
| Sep 30, 2023 | 53.11% |
| Jun 30, 2023 | 53.22% |
| Mar 31, 2023 | 53.55% |
| Dec 31, 2022 | 54.37% |
| Sep 30, 2022 | 54.73% |
| Jun 30, 2022 | 57.16% |
| Mar 31, 2022 | 57.51% |
| Dec 31, 2021 | 54.57% |
| Sep 30, 2021 | 58.43% |